𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost effectiveness of intradermal vs. subcutaneous hepatitis b vaccination for the mentally handicapped

✍ Scribed by Jun Hayashi; Koya Nakashima; Akinori Noguchi; Miki Morofuji; Seizaburo Kashiwagi


Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
375 KB
Volume
23
Category
Article
ISSN
0163-4453

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Long term observation of the effect of i
✍ J. Hayashi; A. Noguchi; K. Nakashima; M. Morofuji; S. Kashiwagi πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 444 KB

Sixty-two patients of two institutions for mentally retarded patients were immunized intradermally with 4 micrograms doses of plasma-derived hepatitis B vaccine made in Japan, initially at month 0.1 and 6. The three vaccinations induced antibodies in 93.5% (90.9% in those with Down's syndrome (DS),

Prevalence of hepatitis B virus markers
✍ Diana Carrascosa; Ma De La Vega RamΓ­rez; Angela Casado; Ma Roserio Je La Torre; πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 440 KB πŸ‘ 2 views

In order to determine the prevalence of hepatitis B virus (HBV) markers, 400 patients were studied: 134 residents of an institution (RI) for the mentally retarded and 266 under non-residential care (NRC). In the residential institutions, all markers were absent in 69 (65.7%) of 105 patients with Dow

Cost effectiveness of interferon Ξ±2b com
✍ Zobair M. Younossi; Mendel E. Singer; John G. McHutchison; Kenneth M. Shermock πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 1 views

## Treatment of chronic hepatitis C with Interferon (IFN) ␣2b monotherapy results in 10% to 15% sustained virological response (SVR). Combining IFN with ribavirin increases this response. In this analysis, using the Markov model, 6 treatment strategies for chronic hepatitis C (previously untreated